Aytu BioPharma Inc. (AYTU)
AYTU trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.99
+1.01% on the day
Market cap
$21.6M
Nano cap
Revenue · 2025
$66.4M
+1.8% on 2024
Net income · 2025
-$13.6M
-20.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AYTU on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001385818 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $66.4M |
| Net income | -$13.6M |
| Operating income | -$7.8M |
| Net margin | -20.4% |
| Operating margin | -11.8% |
| Revenue growth | +1.8% |
| Cash | $30.0M |
| Total assets | $122.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B4 | 424B4 | 2025-06-09 |
| Latest annual report FORM 10-K | 10-K | 2026-09-22 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-05-13 |
| Latest current report FORM 8-K | 8-K | 2026-09-22 |
| Latest proxy FORM DEFA14A | DEFA14A | 2025-10-24 |
Source: SEC EDGAR submissions feed, 905 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| UPC | Universe Pharmaceuticals Inc. | $4.27 | +3.39% | $21.5M |
| COCP | Cocrystal Pharma Inc. | $1.08 | +1.89% | $20.8M |
| TXMD | TherapeuticsMD Inc. | $1.96 | -2.97% | $22.7M |
| OPTH | Optimi Health Corp. Common Shares | $3.50 | -3.58% | $20.0M |
| QNRX | Quoin Pharmaceuticals Ltd. | $4.15 | -4.82% | $19.9M |
| KYNB | Kyntra Bio Inc. | $5.87 | -4.08% | $23.8M |
| PBM | Psyence Biomedical Ltd. Common Shares | $4.55 | -4.01% | $24.2M |
| QNTM | Quantum Biopharma Ltd. Class B Subordinate Voting Shares | $2.89 | +2.48% | $24.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier